<DOC>
	<DOCNO>NCT01003535</DOCNO>
	<brief_summary>Parkinson´s disease base Lewy body degeneration cerebral extracerebral neuron . This Lewy body degeneration include cerebral cholinergic neuron besides dopaminergic neuron . In previous study investigator find clinical parkinsonian symptom - primarily hypokinesia rigidity - significantly correlate dopaminergic nigrostriatal degeneration quantify dopamine transporter image . In contrast , rest postural parkinsonian tremor correlate dopaminergic nigrostriatal degeneration . Obviously cerebral change - instance possible change / degeneration cerebral cholinergic neuron - contribute parkinsonian tremor . In study investigator apply cerebral 5-IA-85380-SPECT quantify local density cerebral nicotinergic cholinergic receptor patient Parkinson´s disease . The investigator correlate result cerebral 5-IA-85380-SPECT clinical parkinsonian main symptom hypokinesia , rigidity primarily rest postural tremor . In particular , interest whether change cerebral cholinergic neuron involve generation parkinsonian tremor .</brief_summary>
	<brief_title>Quantification Cerebral Cholinergic Function Parkinson´s Disease Means Nuclear Medicine Methods</brief_title>
	<detailed_description>The protocol study - explain follow - approve Local Ethics committee ( Ethics committee medical association Saarland , D-66111 Saarbrücken , Germany , file number 201/06 ) German Federal Agency Radiation Protection ( Bundesamt für Strahlenschutz , D-38201 Salzgitter , Germany , file number Z 5 - 22461/2 2008-207 ) . Aims study : In study measure density local distribution cerebral acetylcholine receptor patient Parkinson´s disease ( PD ) mean [ 123I ] 5-IA-85380 SPECT . [ 123I ] 5-IA-85380 SPECT apply healthy volunteer ( Fujita et al . 2002 , Fujita et al . 2003 , Ding et al . 2004 , Mamede et al . 2004 , Obrzut et al . 2005 ) PD patient ( Fukuyama et al . 2004 , Bucerius et al . 2006 , Fujita et al . 2006 ) . These numerous previous study prove [ 123I ] 5-IA-85380 SPECT safe effective method visualize cerebral acetylcholine receptor . We intend correlate density distribution cerebral acetylcholine receptor clinical parkinsonian cardinal symptom tremor , hypokinesia rigidity . The patient out-patients treat Department Neurology , Saarland University , D-66421 Homburg/Saar , Germany . The nuclear medicine measurement [ 123I ] 5-IA-85380 SPECT perform Department Nuclear medicine University Würzburg , D-97080 Würzburg , Germany . This study answer follow question : 1 . Does density acetylcholine receptor putamen , caudate nucleus , thalamus pons correlate severity clinical symptom hypokinesia , rigidity , rest tremor , postural tremor ? 2 . Do PD patient tremor dominant type , akinetic rigid type equivalence type differ concern accumulation 5-IA-85380 ( =density acetylcholine receptor ) putamen , caudate nucleus , thalamus pons ? Study protocol : This study include 25 patient Parkinson´s disease ( PD ) , Hoehn Yahr stage 1 . 25 patient include , correlation coefficient r = 0.5 , error 1st order = 0.05 error 2nd order = 0.20 assume . In addition , number 25 patient sufficient previous study obtain significant result . Due stochastic risk radiation-induced long-term side effect ( example neoplasms ) , high young patient , low age limit include patient determine 50 year . The upper age limit 75 year , since vascular cerebral change increase exponentially high age . The antiparkinsonian medication - except anticholinergic medication - continued nuclear medicine examination previous study exclude interference antiparkinsonian medication - except anticholinergic medication - 5-IA-85380 SPECT . The severity clinical parkinsonian motor symptom hypokinesia , rigidity , rest tremor postural tremor quantify mean motor part UPDRS ( Unified Parkinson´s Disease Rating Scale ) . The UPDRS measure `` Off '' -state ; `` Off '' -state mean medication interrupt least twelve hour . Further Mini Mental State-Test DemTect measure . Healthy control include since exist norm value literature ( Fujita et al . 2002 , Fujita et al . 2003 , Ding et al . 2004 , Mamede et al . 2004 , Obrzut et al . 2005 ) . The tracer [ 123I ] 5-IA-85380 produce laboratory radiochemistry radiopharmacy University Würzburg day examination . This laboratory official permission produce radiotracers . After informed consent patient thyroid gland block perchlorate , radioactively marked tracer [ 123I ] 5-IA-85380 ( 185 MBq ) give intravenously . Cerebral SPECT imaging perform 2-3 hour intravenous injection radioactive substance [ 123I ] 5-IA-85380 . A triple-head gamma camera equip low-energy high-resolution collimator use . Data acquire 128 x 128 matrix cover 120 degree per camera head , 50 second per view . A total 120 view acquire . Statistical analysis : The correlation density acetylcholine receptor ( = uptake [ 123I ] 5-IA-85380 ) different brain region correlate severity clinical symptom . The latter quantified item UPDRS score . Correlations calculate use Pearson´s correlation coefficient case normally distribute data Spearman´s correlation coefficient case normally distribute data .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Cholinergic Agents</mesh_term>
	<criteria>patient Parkinson´s disease ( UK Brain Bank criterion ) Hoehn Yahr stage 1 age 50 75 year nonsmoker inform consent participate study pregnant nursing woman adequate contraception woman capable childbearing male patient live fertile woman without adequate contraception smoker actual past drug alcohol abuse dementia ( minimental state test &lt; 25 point ) psychosis antipsychotic medication last 12 month cholinergic anticholinergic medication unstable severe internal disease</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Parkinson´s disease</keyword>
	<keyword>Acetylcholine receptor</keyword>
</DOC>